Page 5 - Ladyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ladyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ladyn Today - Breaking & Trending Today

Meta, Cal-Maine Foods, Dyne Therapeutics, Intel, Walgreens, and More Market Movers

Meta Platforms CEO Mark Zuckerberg sells about $428 million of company stock over the final two months of 2023, earnings at Cal-Maine Foods widely miss. ....

Federal Reserve , Wall Street , Getty Images , Article Normal , Poultry Farming , Biotechnology Services , Computers Consumer Electronics , Computer Storage Devices , Artificial Intelligence Technologies , Wooden Furniture , Retail Wholesale , Pharmacies Drugstores , Motor Vehicle Dealing , New Car Dealing , Specialty Retailing , Market Research Public Relations , Public Relations , Healthcare Life Sciences , Sports Teams Clubs , Performing Arts Sports Promotion , Advertising Marketing Public Relations , Business Consumer Services , Biological Therapy , Consumer Goods , Computer Peripherals , Computer Hardware ,

Dyne Therapeutics Shares Soar Premarket on Positive Study Data

By Colin Kellaher Shares of Dyne Therapeutics took flight in premarket trading Wednesday after the clinical-stage muscle-disease company reported positive. ....

Colin Kellaher , Dyne Therapeutics , Article Normal , Biotechnology Services , Healthcare Life Sciences , Biological Therapy , Healthcare Provision , Financial Performance , Share Price Movement Disruptions , New Products Services , Research Development , Corporate Industrial News , Products Services , New Product Service Testing , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Share Price Movement , New Products , Industrial News , New Product , Service Testing , Life Sciences ,

Dyne Therapeutics Shares Slide 7.3% On Stock Offering

By Denny Jacob Dyne Therapeutics shares slide 7.3% to $13.69 in post-market trading after it said it commenced an underwritten public offering of $175. ....

Denny Jacob , Article Normal , Biotechnology Services , Healthcare Life Sciences , Biological Therapy , Healthcare Provision , Financial Performance , Share Price Movement Disruptions , Corporate Funding , Share Capital , Corporate Actions , Corporate Industrial News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Dyne Therapeutics , Share Price Movement , Industrial News , Life Sciences ,

Dyne Therapeutics (NYSE:DYN) Upgraded by StockNews.com to "Sell"

StockNews.com upgraded shares of Dyne Therapeutics (NYSE:DYN – Free Report) to a sell rating in a report published on Friday morning. Several other research analysts have also commented on DYN. Chardan Capital reiterated a buy rating and set a $20.00 price objective on shares of Dyne Therapeutics in a research note on Friday, August 4th. […] ....

United States , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , Metlife Investment Management , Dyne Therapeutics Company Profile , Jpmorgan Chase Co , Dyne Therapeutics Inc , Swiss National Bank , Dyne Therapeutics , Free Report , Moderate Buy , Get Free Report , Gatti High , National Bank , Life Investment Management , Fund Advisors , Schwab Investment Management , Dyne Therapeutics Daily , Nyse Dyn , Stocknews Com ,

Dyne Therapeutics (NYSE:DYN) Releases Quarterly Earnings Results

Dyne Therapeutics (NYSE:DYN – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.99) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.16), MarketWatch Earnings reports. Dyne Therapeutics Price Performance Shares of NYSE DYN opened at $7.05 on Wednesday. The stock’s 50-day simple moving average is […] ....

United States , Dyne Therapeutics Inc , Securities Exchange Commission , Jpmorgan Chase Co , Blackrock Inc , Goldman Sachs Group Inc , Dyne Therapeutics , Get Free Report , Marketwatch Earnings , Chardan Capital , Gatti High , Exchange Commission , Street Corp , Sachs Group , Wasatch Advisors , Dyne Therapeutics Daily , Nyse Dyn ,